Related Experiment Video

Updated: Mar 13, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.6K

Cytomegalovirus as an oncomodulatory agent in the progression of glioma

Gabriel P Joseph1, Ryan McDermott2, Maria A Baryshnikova3

  • 1Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, 550 17th Avenue, Seattle, WA 98122, USA.

Cancer Letters
|November 7, 2016
PubMed

Insights

Cytomegalovirus (CMV) promotes aggressive brain tumor (glioblastoma) growth by inhibiting cell death and fueling cancer stem cells. Understanding CMV

Area of Science:

  • Neuro-oncology
  • Virology
  • Cancer Biology

Background:

  • Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with poor prognosis.
  • Understanding glioma progression mechanisms is crucial for developing new therapeutic targets.
  • Cytomegalovirus (CMV) has been investigated for its potential role in cancer development and progression.

Purpose of the Study:

  • To investigate the mechanisms by which cytomegalovirus (CMV) acts as an oncomodulatory agent in glioma.
  • To evaluate the role of CMV in promoting glioma progression and host immunosuppression.
  • To examine the interaction of CMV with host cellular signaling pathways in brain tumors.

Main Methods:

  • Comprehensive review of recent investigative developments.
  • Analysis of cellular processes influenced by CMV during glioma growth.
  • Examination of CMV's interaction with host regulatory signaling pathways.

Main Results:

  • CMV exhibits oncomodulatory effects in brain tumors.
  • CMV inhibits apoptosis (programmed cell death) in glioma cells.
  • CMV promotes the growth of glioma stem cells, contributing to tumor survival and recurrence.

Conclusions:

  • CMV plays a significant role in the progression of glioblastoma.
  • CMV's oncomodulatory effects, including apoptosis inhibition and glioma stem cell promotion, are key mechanisms.
  • Targeting CMV interactions may offer new therapeutic strategies for glioblastoma.
Keywords:
Brain tumorCMVGlioblastomaOncomodulatory agent

More Related Videos

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

14.9K
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

10.2K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
Tumor Progression02:07

Tumor Progression

3.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K